Get informed when a big investor buys or sells
+ FollowOvervalued by 122.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $10.77 Million |
|---|---|
| Enterprise Value | $12.84 Million |
| Earnings per Share | $-0.33 |
| Beta | 0.81 |
| Outstanding Shares | 21,218,264 |
| P/E Ratio | -1.79 |
|---|---|
| PEG | 3.97 |
| Price to Sales | - |
| Price to Book Ratio | 0.51 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.79 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.59 |
| Debt to Equity | 0.35 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospac...